SecSonar.com

GRI Bio, Inc. (GRI)

GRI Bio, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

GRI Bio, Inc. (GRI) is a Biotechnology company based in US with a market capitalization of $189.5K. Free cash flow was negative at -$10.2M. This page tracks GRI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 3 employees · IPO Apr 24, 2023

Valuation

Valuation & price

$2.03 · as of May 17, 2026 · -96.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.03

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$63.28$32.55$1.82Jul 25Dec 25Jul 26Jul 7, 25$41.16Jul 9, 25$46.48Jul 11, 25$46.48Jul 15, 25$50.40Jul 17, 25$54.60Jul 21, 25$55.72Jul 23, 25$57.12Jul 25, 25$55.72Jul 29, 25$54.88Jul 31, 25$35.84Aug 4, 25$35.84Aug 6, 25$35.00Aug 11, 25$32.76Aug 13, 25$36.40Aug 15, 25$38.92Aug 19, 25$39.76Aug 21, 25$38.92Aug 25, 25$40.32Aug 27, 25$40.04Aug 29, 25$38.92Sep 3, 25$40.88Sep 5, 25$46.48Sep 9, 25$43.96Sep 11, 25$57.40Sep 16, 25$54.04Sep 18, 25$54.04Sep 22, 25$56.00Sep 24, 25$59.64Sep 26, 25$54.60Sep 30, 25$57.68Oct 2, 25$55.16Oct 6, 25$56.00Oct 8, 25$53.48Oct 10, 25$52.08Oct 14, 25$53.48Oct 16, 25$54.60Oct 21, 25$63.28Oct 23, 25$56.84Oct 27, 25$56.56Oct 29, 25$49.56Oct 31, 25$47.60Nov 4, 25$46.76Nov 6, 25$49.28Nov 10, 25$48.72Nov 12, 25$52.36Nov 14, 25$47.32Nov 18, 25$50.12Nov 20, 25$57.12Nov 25, 25$57.68Nov 28, 25$56.00Dec 2, 25$54.60Dec 4, 25$59.92Dec 8, 25$37.80Dec 10, 25$33.88Dec 12, 25$14.78Dec 16, 25$13.40Dec 18, 25$10.35Dec 22, 25$9.55Dec 24, 25$9.04Dec 29, 25$6.94Jan 2, 26$7.84Jan 6, 26$8.45Jan 8, 26$7.95Jan 12, 26$6.78Jan 14, 26$6.66Jan 16, 26$6.23Jan 21, 26$6.24Jan 23, 26$5.64Jan 27, 26$5.32Jan 29, 26$3.32Feb 2, 26$2.86Feb 4, 26$2.64Feb 9, 26$2.45Feb 11, 26$2.39Feb 13, 26$2.31Feb 18, 26$2.51Feb 20, 26$2.49Feb 24, 26$2.40Feb 26, 26$2.58Mar 2, 26$2.54Mar 4, 26$2.40Mar 6, 26$2.57Mar 10, 26$2.75Mar 12, 26$2.92Mar 17, 26$2.58Mar 19, 26$2.61Mar 23, 26$2.59Mar 25, 26$2.37Mar 27, 26$2.28Mar 31, 26$2.29Apr 2, 26$2.38Apr 7, 26$2.30Apr 9, 26$2.36Apr 13, 26$2.40Apr 15, 26$2.47Apr 17, 26$2.55Apr 22, 26$2.61Apr 24, 26$2.32Apr 28, 26$2.36Apr 30, 26$2.18May 4, 26$2.26May 6, 26$2.36May 8, 26$2.25May 12, 26$2.28May 14, 26$2.15May 18, 26$2.14May 20, 26$2.20May 22, 26$2.06May 28, 26$2.10Jun 1, 26$2.07Jun 3, 26$2.01Jun 5, 26$2.00Jun 9, 26$2.20Jun 11, 26$2.31Jun 15, 26$2.29Jun 17, 26$2.32Jun 22, 26$1.87Jun 24, 26$1.84Jun 26, 26$1.82Jul 2, 26$1.84
$1.7752-week range$63.28
Loading valuation history…

Fundamentals

Key fundamentals

$189.5K

Market cap

—

Revenue growth (YoY)

-0.0%

Gross margin

-$10.2M

Free cash flow (USD)

-$8.2M

Net debt

Net cash position

1399.6%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2018 → 2025

FY 2018$0.00FY 2019$0.00FY 2020$100.0KFY 2021$0.00FY 2022$0.00FY 2023$0.00FY 2024$22.5MFY 2025$0.00
$0$0

Free cash flow by year

2018 → 2025

FY 2018$-2.4MFY 2019$-2.9MFY 2020$-3.7MFY 2021$-847.0KFY 2022$-1.1MFY 2023$-9.0MFY 2024$-8.6MFY 2025$-10.2M
-$2.4M-$10.2M

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventFDA Orphan Drug DesignationJun 18, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing

Questions

Frequently asked questions

What is GRI Bio, Inc.'s market cap?

GRI Bio, Inc. (GRI) has a market capitalization of $189.5K.

What is GRI's P/E ratio?

A meaningful P/E ratio is not available for GRI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is GRI's price-to-book (P/B) ratio?

GRI trades at 0.03 times book value per share.

Are insiders buying GRI stock?

SEC Form 4 filings show no open-market insider buys at GRI Bio, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

JAGX

Jaguar Health, Inc.

$211.9K

NXTS

N2OFF, Inc.

$333.3K

ADTX

Aditxt, Inc.

$4K

PPBT

Purple Biotech Ltd.

$396K

ONCO

Onconetix, Inc.

$400.8K

SPRC

SciSparc Ltd.

$523.4K

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.